| Literature DB >> 30266746 |
Sen Ma1, Cheng Ouyang2, Shuxin Ren2.
Abstract
To investigate the association between single nucleotide polymorphisms (SNPs) of A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 14 (ADAMTS14) gene and susceptibility to knee osteoarthritis (KOA) in Chinese Han population. Using a case-control design, we enrolled 346 KOA patients and 480 healthy controls. Peripheral blood samples were extracted from each subject. Genotype was determined by sequencing PCR products. The genotype frequencies between cases and controls were compared. The genotype distribution was in accordance with Hardy-Weinberg equilibrium. The minor G allele in case group was significantly higher than in the control group (21.4 compared with 8.8%, P=0.000, odds ratio (OR) = 1.71 (95% confidence interval (CI): 1.39-2.11). The GG genotype and the GG/AG combination were more common in the osteoarthritis (OA) group than in the control group. Compared with AA genotype, the GG (OR = 3.09, 95%CI: 2.01-4.75), AG (OR = 2.55, 95%CI: 1.64-3.96), and GG/AG (OR = 1.57, 95%CI: 1.19-2.07) increased the risk of OA. Multiple logistic confirmed the findings by adjusting some potential factors. Subgroup analysis indicated that the ras4747096 was still significantly associated with KOA. There were no significant differences in allele frequency or genotypes frequency for erythrocyte sedimentation rate and C-reaction protein in OA patients (P>0.05). ADAMTS14 gene polymorphism was associated with KOA, and the GG genotype increased the risk of KOA in Chinese Han population. The ADAMTS14 may be a diagnostic marker and therapeutic target for KOA treatment. The future study should explore the specific molecular mechanism.Entities:
Keywords: ADAMTS14; Hardy-Weinberg; gene polymorphism; knee osteoarthritis
Mesh:
Substances:
Year: 2018 PMID: 30266746 PMCID: PMC6200697 DOI: 10.1042/BSR20181413
Source DB: PubMed Journal: Biosci Rep ISSN: 0144-8463 Impact factor: 3.840
Figure 1The GTEx dataset revealed a significant eQTL association between the rs4747096 genotype and expression of the ADAMTS14 in peripheral whole blood cells
Comparison of general characteristics between case and control groups
| Factors | Case group ( | Control group ( | χ2/t | |
|---|---|---|---|---|
| Gender | 0.516 | 0.472 | ||
| Male | 170 (49.1%) | 248 (51.7) | ||
| Female | 176 (50.9%) | 232 (48.3) | ||
| Age | 57.1 ± 7.0 | 56.6 ± 7.0 | −1.086 | 0.278 |
| BMI | 23.6 ± 3.0 | 23.8 ± 3.1 | 0.622 | 0.534 |
| Course of disease | 1.2 ± 0.8 | 1.1 ± 0.7 | 1.907 | 0.056 |
| Smoking | 3.352 | 0.067 | ||
| Yes | 114 (32.9%) | 188 (39.2%) | ||
| No | 232 (67.1%) | 292 (60.8%) | ||
| Drinking | 0.725 | 0.394 | ||
| Yes | 100 (28.9%) | 152 (31.7%) | ||
| No | 246 (71.1%) | 328 (68.3%) | ||
| Kellgren–Lawrence grading | - | |||
| I/II | 206 (59.5%) | |||
| III/IV | 140 (40.5%) | |||
| ESR ≥ 20 | 180 (52.0%) | - | ||
| CRP > 8 mg/l | 229 (66.2%) | - | ||
| rs4747096 | 28.110 | 0.000 | ||
| AA | 146 (42.2%) | 256 (53.3%) | ||
| AG | 126 (36.4%) | 182 (37.9%) | ||
| GG | 74 (21.4%) | 42 (8.8%) |
Logistic regression analysis of associations between ADAMTS14/rs4747096 gene polymorphism and KOA
| Genotype | Cases | Control | OR (95% CI) | aOR (95%CI) | ||||
|---|---|---|---|---|---|---|---|---|
| % | % | |||||||
| GG compared with AA | 74/146 | 21.4/42.2 | 42/256 | 8.8/53.3 | 3.09 (2.01–4.75) | 0.000 | 3.26 (2.11–5.04) | 0.000 |
| GG compared with AG | 74/126 | 21.4/36.4 | 42/182 | 8.8/37.9 | 2.55 (1.64–3.96) | 0.000 | 2.57 (1.65–4.02) | 0.000 |
| GG/AG compared with AA | 200/146 | 57.8/42.2 | 224/256 | 46.7/53.3 | 1.57 (1.19–2.07) | 0.002 | 1.60 (1.21–2.12) | 0.001 |
| GG compared with AG/AA | 74/272 | 21.4/78.6 | 42/438 | 8.8/91.2 | 2.84 (1.89–4.27) | 0.000 | 2.98 (1.98–4.51) | 0.000 |
| G compared with A | 274/418 | 39.6/60.4 | 266/694 | 27.7/72.3 | 1.71 (1.39–2.11) | 0.000 | - | - |
Abbreviation: aP, adjusted P value; aOR, adjust OR: adjust age, gender, smoking, drinking, and BMI.
Subgroup analyses between ADAMTS14/rs4747096 gene polymorphism and the risk of KOA
| Variables | rs4747096 (Case/control) | GG compared with AA | GG compared with AG | GG/AG compared with AA | GG compared with AG/AA | G compared with A | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AA | AG | GG | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | ||||||
| Sex | |||||||||||||
| Male | 73/132 | 63/96 | 34/20 | 3.07 (1.65–5.73) | 0.020 | 2.59 (1.37–4.89) | 0.003 | 1.51 (1.02–2.24) | 0.039 | 2.85 (1.58–2.15) | 0.001 | 1.66 (1.24–2.23) | 0.001 |
| Female | 73/124 | 63/86 | 40/22 | 3.09 (1.70–5.60) | 0.000 | 2.48 (1.34–4.58) | 0.004 | 1.62 (1.09–2.41) | 0.017 | 2.80 (1.60–4.93) | 0.000 | 1.76 (1.31–2.36) | 0.000 |
| Age (years) | |||||||||||||
| <60 | 78/156 | 82/118 | 50/28 | 3.57 (2.09–6.11) | 0.000 | 2.57 (1.50–4.42) | 0.001 | 1.28 (0.82–2.01) | 0.277 | 3.05 (1.85–5.05) | 0.000 | 1.89 (1.46–2.45) | 0.000 |
| ≥60 | 68/100 | 40/64 | 24/14 | 2.52 (1.22–5.22) | 0.013 | 2.49 (1.16–5.35) | 0.019 | 1.81 (1.26–2.59) | 0.001 | 2.51 (1.25–5.06) | 0.010 | 1.43 (1.01–2.03) | 0.042 |
| Smoking | |||||||||||||
| Yes | 42/108 | 41/60 | 31/10 | 2.78 (1.57–4.93) | 0.000 | 2.81 (1.57–5.03) | 0.001 | 2.31 (1.43–3.73) | 0.001 | 2.79 (1.62–4.82) | 0.000 | 2.89 (2.01–4.15) | 0.000 |
| No | 104/148 | 85/122 | 43/22 | 3.99 (2.05–7.76) | 0.000 | 2.27 (1.14–4.51) | 0.020 | 1.26 (0.90–1.79) | 0.183 | 3.14 (1.69–5.84) | 0.000 | 1.47 (1.13–1.91) | 0.004 |
| Drinking | |||||||||||||
| Yes | 40/80 | 40/52 | 20/10 | 4.08 (2.35–7.07) | 0.000 | 3.71 (2.11–6.53) | 0.000 | 1.53 (1.10–2.13) | 0.012 | 3.91 (2.31–6.63) | 0.000 | 1.77 (1.38–2.28) | 0.000 |
| No | 106/176 | 86/130 | 54/22 | 2.00 (0.96–4.14) | 0.062 | 1.30 (0.62–2.73) | 0.490 | 1.67 (1.00–2.78) | 0.050 | 1.65 (0.84–3.25) | 0.148 | 1.47 (0.98–2.22) | 0.063 |
| BMI | |||||||||||||
| ≥24 | 63/98 | 55/74 | 27/18 | 3.72 (2.13–6.52) | 0.000 | 2.97 (1.68–5.30) | 0.000 | 1.70 (1.18–2.45) | 0.004 | 2.19 (1.15–4.15) | 0.017 | 0.93 (0.66–1.30) | 0.677 |
| <24 | 83/158 | 71/108 | 47/48 | 2.33 (1.19–4.58) | 0.014 | 2.02 (1.01–4.03) | 0.046 | 1.39 (0.90–2.14) | 0.140 | 3.38 (1.99–5.75) | 0.000 | 1.18 (0.90–1.55) | 0.219 |
Comparison of genotypic and allelic frequencies of ADAMTS14/rs4747096 polymorphism amongst KOA subgroups stratified
| Cases | GG | AG | AA | G | A |
|---|---|---|---|---|---|
| ESR ≥ 20 | 44 (24.4) | 58 (32.2) | 78 (43.3) | 146 (40.6) | 214 (59.4) |
| ESR < 20 | 30 (5.9) | 68 (41.0) | 68 (41.0) | 128 (38.6) | 204 (61.4) |
| | 0.395 | 0.224 | 0.591 | ||
| OR (95%CI) | 1.28 (0.73–2.25) | 0.74 (0.46–1.20) | 1.00 | 1.09 (0.80–1.48) | 1.00 |
| CRP > 8 mg/l | 54 (23.6) | 77 (33.6) | 98 (42.8) | 185 (40.4) | 273 (59.6) |
| CRP ≤ 8 mg/l | 20 (17.1) | 49 (41.9) | 48 (41.0) | 89 (38.0) | 145 (62.0) |
| | 0.376 | 0.302 | 0.548 | ||
| OR (95%CI) | 1.32 (0.71–2.45) | 0.77 (0.47–1.27) | 1.00 | 1.10 (0.80–1.53) | 1.00 |
| Grade I/II | 33 (21.4) | 52 (33.8) | 69 (44.8) | 118 (38.3) | 190 (61.7) |
| Grade III/IV | 41 (21.4) | 74 (38.5) | 66 (50.8) | 156 (43.1) | 206 (56.9) |
| | 0.708 | 0.322 | 0.209 | ||
| OR (95%CI) | 0.90 (0.51–1.58) | 0.78 (0.49–1.27) | 1.00 | 0.82 (0.60–1.12) | 1.00 |